Chiropractors in Koloa, HI Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Dillberg Integrated Healthcare Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2711 Ala Kinoiki, Koloa, HI 96756 Phone: 808-742-9326 Fax: 808-742-9458 |
 Dr. Kyle Sensuke Ueunten, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 5470 Koloa Rd # 2d, Koloa, HI 96756 Phone: 408-623-8849 |
Dr. Edward Franklin De Deo, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5470 Koloa Rd 2d, Koloa, HI 96756 Phone: 808-742-2055 |
Dr. Frank Joseph Davis, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 3176 Poipu Rd, Suite 6, Koloa, HI 96756 Phone: 808-742-9555 |
Dr. Kerry L Dillberg, DC, L.AC. Chiropractor - Nutrition Medicare: Not Enrolled in Medicare Practice Location: 2711 Ala Kinoiki, Koloa, HI 96756 Phone: 808-742-9326 Fax: 808-742-9458 |
News Archive
Results from clinical survey of Oncotype DX on patients with node-positive breast cancer announced
Genomic Health, Inc. today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast cancer.
Sepracor's STEDESA NDA: FDA extends PDUFA action date
Sepracor Inc. today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency now anticipates completing its review of the STEDESA™ (eslicarbazepine acetate) New Drug Application (NDA) on April 30, 2010, which is a three-month extension to the original Prescription Drug User Fee Act (PDUFA) date of January 30, 2010.
After January renomination, a hearing for Tavenner appears likely
The Washington Post inteviewed the Obama administration's pick to head the Centers for Medicare & Medicaid Services.
Women create nationwide movement to eradicate breast cancer
More than 300,000 women from across the U.S. have signed up for the Love/Avon Army of Women creating a nationwide movement to eradicate breast cancer. Eighty percent of the women who have joined the Army of Women have never had breast cancer, but want to play a role in ending the disease once and for all.
Merck announces new data from ongoing C-WORTHY Study in HIV/HCV co-infected patients
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
› Verified 7 days ago